Custom Method Development and Validation Across Multiple Platforms

Supporting Regulatory-Driven Excellence in Pharmaceutical and Medical Device Testing

Need a tailored analytical solution? We develop and validate your custom methods across our entire suite of advanced instrumentation, including triple quadrupole LC-MS/MS, QTOF-MS, and GC-MS systems. All validations rigorously adhere to ICH Q2(R2) guidelines, ensuring reliable and compliant results.

Gateway offers flexible validation of client-specific methods across all in-house instrumentation, including triple quadrupole LC-MS/MS, QTOF-MS, and GC-MS systems. All validations are performed in accordance with ICH Q2(R2) guidelines. Reach out to our analytical experts to learn more!

 

Covering every stage of the drug development journey with our state-of-the-art, FDA-inspected, cGMP-compliant facilities designed to minimize bottlenecks and maximize success.

Facebook
Twitter
LinkedIn

Early-Phase Development

Comprehensive packages designed to navigate clinical & regulatory complexities of parenteral product-package and container-closure development, from concept to market readiness.

Container Closure
Integrity Testing

Quantitative, non-destructive, deterministic leak detection technologies for products stored in vials, syringes, cartridges, flexible containers, and bottles.

Particulate
Analysis

Multi-analytical methods to count, size, and characterize visible and subvisible particulate matter in pharmaceuticals, disposable containers, single-use systems, raw materials, and medical devices.

Medical Device
Analysis

Rigorous studies focused on enumerating particulate matter and identifying potential chemical compounds that could migrate from medical devices into the environment or directly impact patient health.

Extractables
& Leachables

Studies aimed at identifying potentially harmful compounds in manufacturing components and final containers to ensure the safety and efficacy of pharmaceutical products.